, Tracking Stock Market Picks
Enter Symbol:
Allergan, Inc. (AGN) [hlAlert]

up 663.04 %

Allergan, Inc. (AGN) rated Outperform by Credit Suisse

Posted on: Wednesday,  Oct 9, 2013  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Allergan, Inc. (NYSE: AGN) on 10/09/2013. Previously Credit Suisse rated Outperform Allergan, Inc. (NYSE: AGN) on 02/25/2009.,
when the stock price was $40.10. Since then, Allergan, Inc. has gained 663.04% as of 11/24/2015's recent price of $305.98.
If you would have followed the previous Credit Suisse's recommendation on AGN, you would have gained 663.04% of your investment in 2463 days.

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2013 8:25 AM Buy
as of 12/13/2013
1 Week down  -1.65 %
1 Month up  1.86 %
3 Months up  8.78 %
1 YTD up  5.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/3/2009 9:25 AM Buy
54.53 57.00
2/25/2009 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy